BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 21490369)

  • 1. Growth hormone-stimulated insulin-like growth factor-1 expression in rainbow trout (Oncorhynchus mykiss) hepatocytes is mediated by ERK, PI3K-AKT, and JAK-STAT.
    Reindl KM; Kittilson JD; Bergan HE; Sheridan MA
    Am J Physiol Regul Integr Comp Physiol; 2011 Jul; 301(1):R236-43. PubMed ID: 21490369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin inhibits hepatic growth hormone receptor and insulin-like growth factor I mRNA expression by activating the ERK and PI3K signaling pathways.
    Hagemeister AL; Sheridan MA
    Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R490-7. PubMed ID: 18495839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and insulin-like growth factor-1 modulate the lipolytic action of growth hormone by altering signal pathway linkages.
    Bergan-Roller HE; Ickstadt AT; Kittilson JD; Sheridan MA
    Gen Comp Endocrinol; 2017 Jul; 248():40-48. PubMed ID: 28410970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental estrogens inhibit the expression of insulin-like growth factor mRNAs in rainbow trout in vitro by altering activation of the JAK-STAT, AKT-PI3K, and ERK signaling pathways.
    Hanson AM; Kittilson JD; Sheridan MA
    Gen Comp Endocrinol; 2021 Aug; 309():113792. PubMed ID: 33872603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental estrogens inhibit insulin-like growth factor (IGF) receptor mRNA expression, IGF binding, and IGF signaling ex vivo in rainbow trout (Oncorhynchus mykiss).
    Hanson AM; Kittilson JD; Sheridan MA
    Gen Comp Endocrinol; 2023 Jan; 330():114125. PubMed ID: 36116484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury.
    Luo JM; Cen LP; Zhang XM; Chiang SW; Huang Y; Lin D; Fan YM; van Rooijen N; Lam DS; Pang CP; Cui Q
    Eur J Neurosci; 2007 Aug; 26(4):828-42. PubMed ID: 17714182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional state modulates growth hormone-stimulated lipolysis.
    Bergan HE; Kittilson JD; Sheridan MA
    Gen Comp Endocrinol; 2015; 217-218():1-9. PubMed ID: 25957918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKC and ERK mediate GH-stimulated lipolysis.
    Bergan HE; Kittilson JD; Sheridan MA
    J Mol Endocrinol; 2013 Oct; 51(2):213-24. PubMed ID: 23785126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
    Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
    Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dipeptide Pro-Asp promotes IGF-1 secretion and expression in hepatocytes by enhancing JAK2/STAT5 signaling pathway.
    Wang S; Wang G; Zhang M; Zhuang L; Wan X; Xu J; Wang L; Zhu X; Gao P; Xi Q; Zhang Y; Shu G; Jiang Q
    Mol Cell Endocrinol; 2016 Nov; 436():204-10. PubMed ID: 27473671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
    Qiao M; Shapiro P; Kumar R; Passaniti A
    J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravitreal insulin and insulin signaling cascade inhibitors on emmetropization in the chick.
    Penha AM; Burkhardt E; Schaeffel F; Feldkaemper MP
    Mol Vis; 2012; 18():2608-22. PubMed ID: 23112573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I induces proliferation and migration of porcine trophectoderm cells through multiple cell signaling pathways, including protooncogenic protein kinase 1 and mitogen-activated protein kinase.
    Jeong W; Song G; Bazer FW; Kim J
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):175-84. PubMed ID: 24508636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2.
    Barclay JL; Kerr LM; Arthur L; Rowland JE; Nelson CN; Ishikawa M; d'Aniello EM; White M; Noakes PG; Waters MJ
    Mol Endocrinol; 2010 Jan; 24(1):204-17. PubMed ID: 19884384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
    Chetoui N; Boisvert M; Gendron S; Aoudjit F
    Immunology; 2010 Jul; 130(3):418-26. PubMed ID: 20465565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LY 294002, an inhibitor of phosphatidylinositol 3-kinase, inhibits GH-mediated expression of the IGF-I gene in rat hepatocytes.
    Shoba LN; Newman M; Liu W; Lowe WL
    Endocrinology; 2001 Sep; 142(9):3980-6. PubMed ID: 11517177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ERK and PI3K signaling pathways mediate inhibition of insulin-like growth factor-1 receptor mRNA expression by somatostatin.
    Hanson A; Poudyal D; Hagemeister A; Reindl KM; Sheridan MA
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):57-62. PubMed ID: 19815052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
    Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
    Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
    Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
    Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines.
    Li H; Schmid-Bindert G; Wang D; Zhao Y; Yang X; Su B; Zhou C
    Adv Med Sci; 2011; 56(2):275-84. PubMed ID: 22037177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.